Match!

Fearful old world? A commentary on the Second International Summit on human genome editing

Published on Feb 1, 2019in Mammalian Genome2.343
· DOI :10.1007/s00335-018-9791-2
Andy Greenfield29
Estimated H-index: 29
Abstract
Genome editing is revolutionising our ability to modify genomes with exquisite precision for medical and agricultural applications, and in basic research. The first International Summit on Human Genome Editing, organised jointly by the US National Academies of Sciences and Medicine, the Chinese Academy of Sciences and the UK Royal Society, was held in Washington DC at the end of 2015. Its aim was to explore scientific, legal and ethical perspectives on the prospective use of human genome editing as a therapeutic intervention in disease (so-called somatic genome editing) and as a possible intervention in human reproduction (so-called germ-line genome editing). Following that Summit, the Organising Committee had, in a press release, come to the conclusion that: “It would be irresponsible to proceed with any clinical use of germ line editing unless and until (i) the relevant safety and efficacy issues have been resolved, based on appropriate understanding and balancing of risks, potential benefits and alternatives, and (ii) there is broad societal consensus about the appropriateness of the proposed application” (http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12032015a). A report from the US National Academies subsequently reiterated and developed the approach.
  • References (22)
  • Citations (1)
📖 Papers frequently viewed together
201741.04Science
30 Citations
49 Citations
2015
2 Authors (Vj Dzau, Rj Cicerone)
1 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References22
Newest
4 CitationsSource
#1Hui YangH-Index: 19
#2LIYixueH-Index: 57
Last. Lars M. Steinmetz (Stanford University)H-Index: 56
view all 8 authors...
Genome editing tools including CRISPR/Cas9 and base editors hold great promise for correcting pathogenic mutations. Unbiased genome-wide off-target effects of the editing in mammalian cells is required before clinical applications, but determination of the extent of off-target effects has been difficult due to the existence of single nucleotide polymorphisms (SNPs) in individuals. Here, we developed a method named GOTI (Genome-wide Off-target analysis by Two-cell embryo Injection) to detect off-...
4 CitationsSource
#1Andy Greenfield (Medical Research Council)H-Index: 29
3 CitationsSource
#1Fatwa AdikusumaH-Index: 4
#2Sandra Piltz (University of Adelaide)H-Index: 7
Last. Paul Thomas (University of Adelaide)H-Index: 38
view all 10 authors...
25 CitationsSource
#1Dieter Egli (Columbia University)H-Index: 35
#2Michael V. Zuccaro (Columbia University)H-Index: 2
Last. Maria Jasin (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 10
view all 6 authors...
20 CitationsSource
#1Michael KosickiH-Index: 3
#2Kärt TombergH-Index: 6
Last. Allan BradleyH-Index: 116
view all 3 authors...
Cas9-induced double stranded breaks can cause large deletions near the target site and more complex genomic rearrangements in mouse and human stem cells.
245 CitationsSource
#1Gemma F. CodnerH-Index: 8
#2Joffrey MiannéH-Index: 6
Last. Lydia TeboulH-Index: 17
view all 22 authors...
Recent advances in clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) genome editing have led to the use of long single-stranded DNA (lssDNA) molecules for generating conditional mutations. However, there is still limited available data on the efficiency and reliability of this method. We generated conditional mouse alleles using lssDNA donor templates and performed extensive characterization of the resulting mutations. We observed that the use ...
12 CitationsSource
#1Wei-Hsi YehH-Index: 3
#2Hao Chiang (Harvard University)H-Index: 3
Last. David R. Liu (Broad Institute)H-Index: 73
view all 5 authors...
Programmable nucleases can introduce precise changes to genomic DNA through homology-directed repair (HDR). Unfortunately, HDR is largely restricted to mitotic cells, and is typically accompanied by an excess of stochastic insertions and deletions (indels). Here we present an in vivo base editing strategy that addresses these limitations. We use nuclease-free base editing to install a S33F mutation in β-catenin that blocks β-catenin phosphorylation, impedes β-catenin degradation, and upregulates...
23 CitationsSource
#1Julie Steffann (Paris V: Paris Descartes University)H-Index: 4
#2Pierre Jouannet (Paris V: Paris Descartes University)H-Index: 22
Last. Nelly Frydman (Université Paris-Saclay)H-Index: 29
view all 5 authors...
8 CitationsSource
#1Sheila Jasanoff (Harvard University)H-Index: 45
Sheila Jasanoff and J. Benjamin Hurlbut call for an international network of scholars and organizations to support a new kind of conversation. Sheila Jasanoff and J. Benjamin Hurlbut call for an international network of scholars and organizations to support a new kind of conversation.
30 CitationsSource
Cited By1
Newest
#1Achim RosemannH-Index: 7
#2Adam BalenH-Index: 1
Last. Nick LeeH-Index: 1
view all 8 authors...
A central problem for the international governance of heritable germline gene editing is that there are important differences in attitudes and values as well as ethical and health care considerations around the world. These differences are reflected in a complicated and diverse regulatory landscape. Several publications have discussed whether reproductive uses would be legally permissible in individual countries and whether clinical applications could emerge in the context of regulatory gaps and...
2 CitationsSource